Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A11017 / Name: Horizon / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Horizon Discovery Group plc Stock

Pros and Cons of Horizon Discovery Group plc in the next few years

Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Horizon Discovery Group plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Horizon Discovery Group plc - - - - - - -
Exact Sciences 1.920% -3.932% -8.688% -3.222% -19.787% -52.283% -37.134%
Incyte Corp. 0.820% -2.680% -7.597% -27.514% -14.892% -31.813% -27.098%
Regeneron Pharmaceuticals Inc. -0.600% -1.902% -7.281% 17.050% 3.473% 99.083% 169.102%

News

InterAx Biotech Announces Being the Recipient of a Highly Competitive European Grant to Fund Drug Development and Reports Financing Highlights
InterAx Biotech Announces Being the Recipient of a Highly Competitive European Grant to Fund Drug Development and Reports Financing Highlights

InterAx Biotech AG, a pharmaceutical product development company pioneering computational pharmacology for drug discovery, announces being awarded a highly competitive and prestigious grant